Bubs Australia Ltd.

Bubs Australia Ltd.

0.09
AUD
+0.00
(-3.19%)
-0.01EPS
68.85MMarket Cap
Mar 01Next Earn
Bubs Australia Ltd.
ASX:BUB
(Australian Securities Exchange)

Recent

price

0.09

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
AUD
- -
0.1
0.18
- -
- -
- -
0.02
0.05
0.09
0.1
0.06
0.14
0.08
0.1
0.11
0.13
Revenue per Share
-0.67
0.01
-0.07
-0.11
-0.18
-0.03
-0.02
-0.19
-0.08
-0.01
-0.12
-0.02
-0.15
-0.03
0.01
-0.01
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.5
0.51
0.34
0.23
0.03
- -
0.03
0.16
0.2
0.23
0.14
0.14
0.06
0.04
0.05
0.04
Book Value per Share
0.5
0.51
0.34
0.23
0.03
- -
0.02
0.03
-0.14
0.08
0.07
0.08
0.05
0.04
0.05
0.04
Tangible Book Value per Share
4
5
7
8
9
15
206
331
463
547
614
623
739
832
893
894
Basic Weighted Avg Shares
- -
1
1
- -
- -
- -
4
17
44
55
39
89
60
80
103
112
Sales/Revenue/Turnover
- -
-135.18
-43.51
- -
- -
- -
-128.72
-106.38
-85.53
-27.71
-80.67
-12.28
-125.72
-27.27
-1.14
-5.02
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
1
4
3
3
4
1
1
1
Depreciation Expense
-3
- -
- -
-1
-2
-1
-5
-65
-36
-8
-75
-11
-108
-21
6
-5
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
9.46
-38.54
- -
- -
- -
-127.78
-382.1
-80.86
-14.22
-190.11
-12.74
-180.26
-26.33
5.41
-4.13
Profit Margin (%)
2
- -
2
1
- -
- -
7
50
42
46
41
44
35
31
37
33
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
2
1
- -
5
LT Debt
3
3
3
2
- -
- -
8
72
106
132
87
88
42
37
42
39
Total Equity
- -
-26.82
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2.68
- -
Return on Invested Capital (%)
- -
1.88
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
13.68
- -
Return on Capital (%)
-83.43
1.88
-18.8
-39.79
-140.3
-198.86
-132.72
-161.53
-39.88
-6.54
-68.28
-12.99
-166.84
-53.44
13.97
-11.35
Return on Common Equity (%)

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1,456.78%
-11.17%
-8.12%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
317.7%
75.42%
-183.42%
Sales/Revenue/Turnover
- -
32.96%
9.08%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
80
2025
- -
- -
103
2026
- -
- -
112

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.03
2025
- -
- -
0.01
2026
- -
- -
-0.01

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
Bubs Australia Limited (ASX:BUB), Australia's largest producer of goat dairy infant formula and related nutritional products, manufactures and distributes a portfolio of goat milk and organic grass-fed cow milk infant formulas, organic baby foods, goat milk powder for adults, fresh goat dairy products and nutritional supplements; its core offerings include Bubs Goat Infant Formula stages 1-4, Supreme and Caprilac premium goat milk lines, 365-day grass-fed cow formulas and organic cereals sold through supermarkets, pharmacies and e-commerce channels targeting parents seeking premium, clean-label nutrition. The company operates from its headquarters in Dandenong South, Victoria, with vertically integrated production facilities including Australia's largest goat milking herd; it generates revenue primarily from Australia, the United States (its largest export market), China via cross-border e-commerce and daigou channels plus O2O outlets, Southeast Asia, the Middle East, Vietnam and Japan. Founded in 2006 by Kristy-Lee Newland Carr, Bubs reported FY25 net revenue of A$102.5 million, up 29% year-on-year, with US sales surging 52% to A$53.1 million, China up 22% on premium goat formulas and Australia up 8% led by goat infant segment growth; recent leadership changes include the July 2025 appointment of Joe Coote as CEO and managing director with over 20 years in dairy and infant nutrition, alongside Paul Jensen as independent chair in September 2025, as the company advances US permanent market access applications and anticipates FY25 EBITDA of A$5.5-6.0 million versus prior-year losses.

Company News

  • Bubs Australia Limited (BUBSF) Discusses FDA Authorization Milestone and US Growth Strategy in Infant Formula Market Transcript

  • Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump

  • Bubs Australia Limited (BUBSF) Q4 2026 Earnings Call Transcript

  • Bubs Australia Limited (BUBSF) Discusses Strategic Direction, Market Expansion and Shareholder Value Creation Transcript

  • Bubs Australia Limited (BUBSF) Q2 2026 Earnings Call Transcript

  • Bubs Australia Limited (BUBSF) Shareholder/Analyst Call Transcript

  • Bubs Australia shares surge on infant formula supply deal with Walmart